Range
6.94 - 7.38
Vol / Avg.
477.1K/364.1K
Div / Yield
-
52 Wk
4.43 - 14.84
Mkt Cap
358.5M
Payout Ratio
-
Open
7.16
P/E
-
EPS
0.9
Shares
51.2M
Outstanding
51.2M
Total Float
-
load more
Sector: Health Care.Industry: Biotechnology
Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. The company primarily operates only in the United States. The company have developed a suite of integrated technologies that comprise Translational Science Platform, enabling it to comprehensively interrogate the cellular and molecular composition of tumors.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-06
REV
Q1 2021Est.ActualSurprise
EPS-0.410-0.580 -0.1700
REV11.810M1.539M-10.271M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
JNCEJounce Therapeutics-0.99%358.5M

Jounce Therapeutics Frequently Asked Questions

Q

How do I buy Jounce Therapeutics (JNCE) stock?

A

You can purchase shares of Jounce Therapeutics (NASDAQ: JNCE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jounce Therapeutics's (JNCE) competitors?

Q

What is the target price for Jounce Therapeutics (JNCE) stock?

A

The latest price target for Jounce Therapeutics (NASDAQ: JNCE) was reported by Piper Sandler on March 15, 2021. The analyst firm set a price target for 20.00 expecting JNCE to rise to within 12 months (a possible 185.71% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jounce Therapeutics (JNCE)?

A

The stock price for Jounce Therapeutics (NASDAQ: JNCE) is $7 last updated Today at 7:15:17 PM.

Q

Does Jounce Therapeutics (JNCE) pay a dividend?

A

There are no upcoming dividends for Jounce Therapeutics.

Q

When is Jounce Therapeutics (NASDAQ:JNCE) reporting earnings?

A
Jounce Therapeutics’s Q2 earnings are confirmed for after-market on August 6, 2021.
Q

Is Jounce Therapeutics (JNCE) going to split?

A

There is no upcoming split for Jounce Therapeutics.

Q

What sector and industry does Jounce Therapeutics (JNCE) operate in?

A

Jounce Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.